CYCLACEL PHARMACEUTICALS INC - COM (CYCC)

CUSIP: 23254L603

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
2,454,357
Share change
+126,640
Total reported value
$1,633,300
Put/Call ratio
3.7%
Price per share
$0.67
Number of holders
26
Value change
+$51,283
Number of buys
12
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 23254L603?
CUSIP 23254L603 identifies CYCC - CYCLACEL PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q4 2022

As of 31 Dec 2022, CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by 26 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,454,357 shares. The largest 10 holders included Schonfeld Strategic Advisors LLC, ACADIAN ASSET MANAGEMENT LLC, SPHERA FUNDS MANAGEMENT LTD., Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, and HRT FINANCIAL LP. This page lists 26 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.